Bio Roundup: Funding Frenzy, Opioid Summit, Celgene Woes & More
Xconomy
MARCH 2, 2018
Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6
52 
Let's personalize your content